BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference
SAN DIEGO, May 4, 2021 /PRNewswire/ -- BioTheryX, Inc., a [...]
BioTheryX Announces Expansion of Scientific Advisory Board
SAN DIEGO, April 7, 2021 /PRNewswire/ -- BioTheryX, Inc., [...]
BioTheryX to Present at the Barclays Global Healthcare Conference and the Credit Suisse Solebury Trout Healthcare Innovators Conference
SAN DIEGO, March 3, 2021 /PRNewswire/ --BioTheryX, Inc., a clinical-stage [...]
BioTheryX to Participate in Upcoming Scientific and Investor Events
SAN DIEGO, Feb. 15, 2021 /PRNewswire/ -- BioTheryX, Inc., a [...]
BioTheryX Appoints Jamie Donadio as Chief Financial Officer
SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- BioTheryX, Inc., [...]
BioTheryX Appoints Robert F. Williamson, III as President and Chief Executive Officer
SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- BioTheryX, Inc., [...]
BioTheryX Announces $35 Million Series D Financing
SAN DIEGO, CA, July 28, 2020 -- BioTheryX, Inc., [...]
BioTheryX, Inc. Announces the Appointment of Professor Yinon Ben- Neriah, M.D., Ph.D., to its Scientific Advisory Board
Accomplished scientist who created BioTheryX's promising lead clinical candidate [...]
BioTheryX Announces the Initiation of Patient Dosing in a First-in-Man Phase 1 Clinical Trial of BTX-A51
Study is evaluating the safety/tolerability of BTX-A51 in patients [...]
BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directors
Part of BioTheryX's previously announced plan to continue building [...]